Melanin-targeted [<sup>18</sup>F]-PFPN PET imaging may shed light for clear cell sarcoma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 37714979.
- Also identified by DOI 10.1007/s00259-023-06439-2.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intracytoplasmic melanin pigment is a characteristic of clear cell sarcoma (CCS), which is a particularly deadly type of soft-tissue sarcoma. [<sup>18</sup>F]-N-(2-(diethylamino)ethyl)-5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)picolinamide ([<sup>18</sup>F]-PFPN) is a positron emission tomography (PET) probe characterized by high melanin affinity. Therefore, this study aimed to investigate the feasibility of melanin-targeted [<sup>18</sup>F]-PFPN PET in patients with CCS. This prospective single-centre study recruited patients with pathologically confirmed CCS. [<sup>18</sup>F]-FDG PET/computed tomography and [<sup>18</sup>F]-PFPN PET/magnetic resonance imaging scans were performed within 1 week of each other. The lesion numbers and [<sup>18</sup>F]-FDG and [<sup>18</sup>F]-PFPN PET parameters (maximum standardized uptake value [SUVmax], mean standardized uptake value [SUVmean], metabolic/melanotic tumour volume [MTV/MLTV], and total lesion glycolysis/melanin [TLG/TLM]) were collected. Three patients with CCS were recruited and received PET imaging. A total of 56 lesions were detected on [<sup>18</sup>F]-PFPN PET, including primary tumour and distant metastases. Identical lesions were not detected on [<sup>18</sup>F]-PFPN and [<sup>18</sup>F]-FDG PET. Twelve lesions (12/39, 30.77%) on [<sup>18</sup>F]-FDG imaging were missed on [<sup>18</sup>F]-PFPN, and 20 lesions (20/47, 42.55%) on [<sup>18</sup>F]-PFPN imaging were missed on [<sup>18</sup>F]-FDG. In quantitative analysis, the [<sup>18</sup>F]-FDG SUVmean (4.60 ± 3.24) was higher than the [<sup>18</sup>F]-PFPN SUVmean (3.0 ± 2.63) in all lesions (P = 0.01). No significant correlations were found between the SUVmax, SUVmean, MLTV/MTV, and TLM/TLG values of [<sup>18</sup>F]-PFPN and [<sup>18</sup>F]-FDG (P > 0.05). Melanin-targeted [<sup>18</sup>F]-PFPN PET imaging is feasible for the diagnosis of CCS. Different imaging features were displayed on [<sup>18</sup>F]-PFPN and [<sup>18</sup>F]-FDG PET imaging, demonstrating the complementary role of the tracers. Combined use of the two imaging modalities would be preferred in patients with CCS. NCT05963035.
Medical subject headings
- Fluorodeoxyglucose F18
- Sarcoma, Clear Cell